Global Edible Vaccines Market

Edible Vaccines Comprehensive Study by Type (Inactivated Vaccines, Others), Application (Medical Care, Livestock, Others) Players and Region - Global Market Outlook to 2030

Edible Vaccines Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Edible Vaccines
Edible vaccines are vaccines made from transgenic plants which are used to make Bio friendly vaccines and are globally accepted to improve the safety of individuals, as these edible vaccines are non-toxic in nature. Edible vaccines are preferred worldwide to provide nutrition in terms of proteins, vitamins and other nutritional qualities which are primary need vaccines to immunize the consumer against disease. Easy to store ability, cost-effective, easily administrable and noble cause interconnected with edible vaccines market is expected to raise the demand for the forecasted year.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Edible Vaccines market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

GlaxoSmithKline Plc. (United Kingdom), Merck & Co. Inc. (United States), Sanofi-Pasteur (France), Merial (France) and Santa Cruz Animal Health (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Edible Vaccines market by Type (Inactivated Vaccines and Others), Application (Medical Care, Livestock and Others) and Region.



On the basis of geography, the market of Edible Vaccines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Rapid Advancement In Technologies Particularly in the Healthcare Sector

Market Growth Drivers:
High Prevalence of Infectious Diseases, Rising Focus on Immunization Programs and Growing Government Support for Vaccine Developmen

Challenges:
Minimizing the Side Effects

Restraints:
High Cost Involved in Vaccine Development

Opportunities:
High growth prospectus in various regions due to increasing infection and Focus on therapeutic vaccines

Market Leaders and their expansionary development strategies
On October 26, 2023, Plant-based food giant Impossible Foods announced a partnership with Kentucky BioProcessing (KBP) to develop and scale up the production of edible plant-based proteins for use in edible vaccines.
On August 10, 2023, California-based biotechnology company Plantae announced a collaboration with the University of California, Berkeley, to develop a new platform for delivering edible vaccines using genetically modified leafy greens.
The FDA regulates a variety of vaccine types, and is preparing to regulate new products under study, such as "edible vaccines." According to FDA Edible vaccines have some advantages over traditional vaccines. They are unable to cause infection, are relatively easy to produce in large quantities, and are stable during storage. Researchers produce edible vaccines by genetically altering the edible parts of plants. Substances that stimulate an immune response (antigens) to rabies have been produced in tomato plants, and antigens to hepatitis and cholera have been produced in U.S. Food and Drug Administration.

Key Target Audience
Manufacturers and suppliers of Edible vaccines, Research and development companies, Medical research laboratories, Academic medical centers and universities, Research and consulting firms and Venture capital firms

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Inactivated Vaccines
  • Others
By Application
  • Medical Care
  • Livestock
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Prevalence of Infectious Diseases
      • 3.2.2. Rising Focus on Immunization Programs
      • 3.2.3. Growing Government Support for Vaccine Developmen
    • 3.3. Market Challenges
      • 3.3.1. Minimizing the Side Effects
    • 3.4. Market Trends
      • 3.4.1. Rapid Advancement In Technologies Particularly in the Healthcare Sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Edible Vaccines, by Type, Application and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Edible Vaccines (Value)
      • 5.2.1. Global Edible Vaccines by: Type (Value)
        • 5.2.1.1. Inactivated Vaccines
        • 5.2.1.2. Others
      • 5.2.2. Global Edible Vaccines by: Application (Value)
        • 5.2.2.1. Medical Care
        • 5.2.2.2. Livestock
        • 5.2.2.3. Others
      • 5.2.3. Global Edible Vaccines Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Edible Vaccines (Volume)
      • 5.3.1. Global Edible Vaccines by: Type (Volume)
        • 5.3.1.1. Inactivated Vaccines
        • 5.3.1.2. Others
      • 5.3.2. Global Edible Vaccines by: Application (Volume)
        • 5.3.2.1. Medical Care
        • 5.3.2.2. Livestock
        • 5.3.2.3. Others
      • 5.3.3. Global Edible Vaccines Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global Edible Vaccines (Price)
      • 5.4.1. Global Edible Vaccines by: Type (Price)
  • 6. Edible Vaccines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck & Co. Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sanofi-Pasteur (France)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Merial (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Santa Cruz Animal Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
  • 7. Global Edible Vaccines Sale, by Type, Application and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Edible Vaccines (Value)
      • 7.2.1. Global Edible Vaccines by: Type (Value)
        • 7.2.1.1. Inactivated Vaccines
        • 7.2.1.2. Others
      • 7.2.2. Global Edible Vaccines by: Application (Value)
        • 7.2.2.1. Medical Care
        • 7.2.2.2. Livestock
        • 7.2.2.3. Others
      • 7.2.3. Global Edible Vaccines Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Edible Vaccines (Volume)
      • 7.3.1. Global Edible Vaccines by: Type (Volume)
        • 7.3.1.1. Inactivated Vaccines
        • 7.3.1.2. Others
      • 7.3.2. Global Edible Vaccines by: Application (Volume)
        • 7.3.2.1. Medical Care
        • 7.3.2.2. Livestock
        • 7.3.2.3. Others
      • 7.3.3. Global Edible Vaccines Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global Edible Vaccines (Price)
      • 7.4.1. Global Edible Vaccines by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Edible Vaccines: by Type(USD Million)
  • Table 2. Edible Vaccines Inactivated Vaccines , by Region USD Million (2018-2023)
  • Table 3. Edible Vaccines Others , by Region USD Million (2018-2023)
  • Table 4. Edible Vaccines: by Application(USD Million)
  • Table 5. Edible Vaccines Medical Care , by Region USD Million (2018-2023)
  • Table 6. Edible Vaccines Livestock , by Region USD Million (2018-2023)
  • Table 7. Edible Vaccines Others , by Region USD Million (2018-2023)
  • Table 8. South America Edible Vaccines, by Country USD Million (2018-2023)
  • Table 9. South America Edible Vaccines, by Type USD Million (2018-2023)
  • Table 10. South America Edible Vaccines, by Application USD Million (2018-2023)
  • Table 11. Brazil Edible Vaccines, by Type USD Million (2018-2023)
  • Table 12. Brazil Edible Vaccines, by Application USD Million (2018-2023)
  • Table 13. Argentina Edible Vaccines, by Type USD Million (2018-2023)
  • Table 14. Argentina Edible Vaccines, by Application USD Million (2018-2023)
  • Table 15. Rest of South America Edible Vaccines, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Edible Vaccines, by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Edible Vaccines, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Edible Vaccines, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Edible Vaccines, by Application USD Million (2018-2023)
  • Table 20. China Edible Vaccines, by Type USD Million (2018-2023)
  • Table 21. China Edible Vaccines, by Application USD Million (2018-2023)
  • Table 22. Japan Edible Vaccines, by Type USD Million (2018-2023)
  • Table 23. Japan Edible Vaccines, by Application USD Million (2018-2023)
  • Table 24. India Edible Vaccines, by Type USD Million (2018-2023)
  • Table 25. India Edible Vaccines, by Application USD Million (2018-2023)
  • Table 26. South Korea Edible Vaccines, by Type USD Million (2018-2023)
  • Table 27. South Korea Edible Vaccines, by Application USD Million (2018-2023)
  • Table 28. Taiwan Edible Vaccines, by Type USD Million (2018-2023)
  • Table 29. Taiwan Edible Vaccines, by Application USD Million (2018-2023)
  • Table 30. Australia Edible Vaccines, by Type USD Million (2018-2023)
  • Table 31. Australia Edible Vaccines, by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Edible Vaccines, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Edible Vaccines, by Application USD Million (2018-2023)
  • Table 34. Europe Edible Vaccines, by Country USD Million (2018-2023)
  • Table 35. Europe Edible Vaccines, by Type USD Million (2018-2023)
  • Table 36. Europe Edible Vaccines, by Application USD Million (2018-2023)
  • Table 37. Germany Edible Vaccines, by Type USD Million (2018-2023)
  • Table 38. Germany Edible Vaccines, by Application USD Million (2018-2023)
  • Table 39. France Edible Vaccines, by Type USD Million (2018-2023)
  • Table 40. France Edible Vaccines, by Application USD Million (2018-2023)
  • Table 41. Italy Edible Vaccines, by Type USD Million (2018-2023)
  • Table 42. Italy Edible Vaccines, by Application USD Million (2018-2023)
  • Table 43. United Kingdom Edible Vaccines, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Edible Vaccines, by Application USD Million (2018-2023)
  • Table 45. Netherlands Edible Vaccines, by Type USD Million (2018-2023)
  • Table 46. Netherlands Edible Vaccines, by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Edible Vaccines, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Edible Vaccines, by Application USD Million (2018-2023)
  • Table 49. MEA Edible Vaccines, by Country USD Million (2018-2023)
  • Table 50. MEA Edible Vaccines, by Type USD Million (2018-2023)
  • Table 51. MEA Edible Vaccines, by Application USD Million (2018-2023)
  • Table 52. Middle East Edible Vaccines, by Type USD Million (2018-2023)
  • Table 53. Middle East Edible Vaccines, by Application USD Million (2018-2023)
  • Table 54. Africa Edible Vaccines, by Type USD Million (2018-2023)
  • Table 55. Africa Edible Vaccines, by Application USD Million (2018-2023)
  • Table 56. North America Edible Vaccines, by Country USD Million (2018-2023)
  • Table 57. North America Edible Vaccines, by Type USD Million (2018-2023)
  • Table 58. North America Edible Vaccines, by Application USD Million (2018-2023)
  • Table 59. United States Edible Vaccines, by Type USD Million (2018-2023)
  • Table 60. United States Edible Vaccines, by Application USD Million (2018-2023)
  • Table 61. Canada Edible Vaccines, by Type USD Million (2018-2023)
  • Table 62. Canada Edible Vaccines, by Application USD Million (2018-2023)
  • Table 63. Mexico Edible Vaccines, by Type USD Million (2018-2023)
  • Table 64. Mexico Edible Vaccines, by Application USD Million (2018-2023)
  • Table 65. Edible Vaccines Sales: by Type(K Units)
  • Table 66. Edible Vaccines Sales Inactivated Vaccines , by Region K Units (2018-2023)
  • Table 67. Edible Vaccines Sales Others , by Region K Units (2018-2023)
  • Table 68. Edible Vaccines Sales: by Application(K Units)
  • Table 69. Edible Vaccines Sales Medical Care , by Region K Units (2018-2023)
  • Table 70. Edible Vaccines Sales Livestock , by Region K Units (2018-2023)
  • Table 71. Edible Vaccines Sales Others , by Region K Units (2018-2023)
  • Table 72. South America Edible Vaccines Sales, by Country K Units (2018-2023)
  • Table 73. South America Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 74. South America Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 75. Brazil Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 76. Brazil Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 77. Argentina Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 78. Argentina Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 79. Rest of South America Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 80. Rest of South America Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 81. Asia Pacific Edible Vaccines Sales, by Country K Units (2018-2023)
  • Table 82. Asia Pacific Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 83. Asia Pacific Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 84. China Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 85. China Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 86. Japan Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 87. Japan Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 88. India Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 89. India Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 90. South Korea Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 91. South Korea Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 92. Taiwan Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 93. Taiwan Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 94. Australia Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 95. Australia Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 96. Rest of Asia-Pacific Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 97. Rest of Asia-Pacific Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 98. Europe Edible Vaccines Sales, by Country K Units (2018-2023)
  • Table 99. Europe Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 100. Europe Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 101. Germany Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 102. Germany Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 103. France Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 104. France Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 105. Italy Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 106. Italy Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 107. United Kingdom Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 108. United Kingdom Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 109. Netherlands Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 110. Netherlands Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 111. Rest of Europe Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 112. Rest of Europe Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 113. MEA Edible Vaccines Sales, by Country K Units (2018-2023)
  • Table 114. MEA Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 115. MEA Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 116. Middle East Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 117. Middle East Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 118. Africa Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 119. Africa Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 120. North America Edible Vaccines Sales, by Country K Units (2018-2023)
  • Table 121. North America Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 122. North America Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 123. United States Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 124. United States Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 125. Canada Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 126. Canada Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 127. Mexico Edible Vaccines Sales, by Type K Units (2018-2023)
  • Table 128. Mexico Edible Vaccines Sales, by Application K Units (2018-2023)
  • Table 129. Edible Vaccines: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Edible Vaccines: by Type(USD Million)
  • Table 136. Edible Vaccines Inactivated Vaccines , by Region USD Million (2025-2030)
  • Table 137. Edible Vaccines Others , by Region USD Million (2025-2030)
  • Table 138. Edible Vaccines: by Application(USD Million)
  • Table 139. Edible Vaccines Medical Care , by Region USD Million (2025-2030)
  • Table 140. Edible Vaccines Livestock , by Region USD Million (2025-2030)
  • Table 141. Edible Vaccines Others , by Region USD Million (2025-2030)
  • Table 142. South America Edible Vaccines, by Country USD Million (2025-2030)
  • Table 143. South America Edible Vaccines, by Type USD Million (2025-2030)
  • Table 144. South America Edible Vaccines, by Application USD Million (2025-2030)
  • Table 145. Brazil Edible Vaccines, by Type USD Million (2025-2030)
  • Table 146. Brazil Edible Vaccines, by Application USD Million (2025-2030)
  • Table 147. Argentina Edible Vaccines, by Type USD Million (2025-2030)
  • Table 148. Argentina Edible Vaccines, by Application USD Million (2025-2030)
  • Table 149. Rest of South America Edible Vaccines, by Type USD Million (2025-2030)
  • Table 150. Rest of South America Edible Vaccines, by Application USD Million (2025-2030)
  • Table 151. Asia Pacific Edible Vaccines, by Country USD Million (2025-2030)
  • Table 152. Asia Pacific Edible Vaccines, by Type USD Million (2025-2030)
  • Table 153. Asia Pacific Edible Vaccines, by Application USD Million (2025-2030)
  • Table 154. China Edible Vaccines, by Type USD Million (2025-2030)
  • Table 155. China Edible Vaccines, by Application USD Million (2025-2030)
  • Table 156. Japan Edible Vaccines, by Type USD Million (2025-2030)
  • Table 157. Japan Edible Vaccines, by Application USD Million (2025-2030)
  • Table 158. India Edible Vaccines, by Type USD Million (2025-2030)
  • Table 159. India Edible Vaccines, by Application USD Million (2025-2030)
  • Table 160. South Korea Edible Vaccines, by Type USD Million (2025-2030)
  • Table 161. South Korea Edible Vaccines, by Application USD Million (2025-2030)
  • Table 162. Taiwan Edible Vaccines, by Type USD Million (2025-2030)
  • Table 163. Taiwan Edible Vaccines, by Application USD Million (2025-2030)
  • Table 164. Australia Edible Vaccines, by Type USD Million (2025-2030)
  • Table 165. Australia Edible Vaccines, by Application USD Million (2025-2030)
  • Table 166. Rest of Asia-Pacific Edible Vaccines, by Type USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Edible Vaccines, by Application USD Million (2025-2030)
  • Table 168. Europe Edible Vaccines, by Country USD Million (2025-2030)
  • Table 169. Europe Edible Vaccines, by Type USD Million (2025-2030)
  • Table 170. Europe Edible Vaccines, by Application USD Million (2025-2030)
  • Table 171. Germany Edible Vaccines, by Type USD Million (2025-2030)
  • Table 172. Germany Edible Vaccines, by Application USD Million (2025-2030)
  • Table 173. France Edible Vaccines, by Type USD Million (2025-2030)
  • Table 174. France Edible Vaccines, by Application USD Million (2025-2030)
  • Table 175. Italy Edible Vaccines, by Type USD Million (2025-2030)
  • Table 176. Italy Edible Vaccines, by Application USD Million (2025-2030)
  • Table 177. United Kingdom Edible Vaccines, by Type USD Million (2025-2030)
  • Table 178. United Kingdom Edible Vaccines, by Application USD Million (2025-2030)
  • Table 179. Netherlands Edible Vaccines, by Type USD Million (2025-2030)
  • Table 180. Netherlands Edible Vaccines, by Application USD Million (2025-2030)
  • Table 181. Rest of Europe Edible Vaccines, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe Edible Vaccines, by Application USD Million (2025-2030)
  • Table 183. MEA Edible Vaccines, by Country USD Million (2025-2030)
  • Table 184. MEA Edible Vaccines, by Type USD Million (2025-2030)
  • Table 185. MEA Edible Vaccines, by Application USD Million (2025-2030)
  • Table 186. Middle East Edible Vaccines, by Type USD Million (2025-2030)
  • Table 187. Middle East Edible Vaccines, by Application USD Million (2025-2030)
  • Table 188. Africa Edible Vaccines, by Type USD Million (2025-2030)
  • Table 189. Africa Edible Vaccines, by Application USD Million (2025-2030)
  • Table 190. North America Edible Vaccines, by Country USD Million (2025-2030)
  • Table 191. North America Edible Vaccines, by Type USD Million (2025-2030)
  • Table 192. North America Edible Vaccines, by Application USD Million (2025-2030)
  • Table 193. United States Edible Vaccines, by Type USD Million (2025-2030)
  • Table 194. United States Edible Vaccines, by Application USD Million (2025-2030)
  • Table 195. Canada Edible Vaccines, by Type USD Million (2025-2030)
  • Table 196. Canada Edible Vaccines, by Application USD Million (2025-2030)
  • Table 197. Mexico Edible Vaccines, by Type USD Million (2025-2030)
  • Table 198. Mexico Edible Vaccines, by Application USD Million (2025-2030)
  • Table 199. Edible Vaccines Sales: by Type(K Units)
  • Table 200. Edible Vaccines Sales Inactivated Vaccines , by Region K Units (2025-2030)
  • Table 201. Edible Vaccines Sales Others , by Region K Units (2025-2030)
  • Table 202. Edible Vaccines Sales: by Application(K Units)
  • Table 203. Edible Vaccines Sales Medical Care , by Region K Units (2025-2030)
  • Table 204. Edible Vaccines Sales Livestock , by Region K Units (2025-2030)
  • Table 205. Edible Vaccines Sales Others , by Region K Units (2025-2030)
  • Table 206. South America Edible Vaccines Sales, by Country K Units (2025-2030)
  • Table 207. South America Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 208. South America Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 209. Brazil Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 210. Brazil Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 211. Argentina Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 212. Argentina Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 213. Rest of South America Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 214. Rest of South America Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 215. Asia Pacific Edible Vaccines Sales, by Country K Units (2025-2030)
  • Table 216. Asia Pacific Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 217. Asia Pacific Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 218. China Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 219. China Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 220. Japan Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 221. Japan Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 222. India Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 223. India Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 224. South Korea Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 225. South Korea Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 226. Taiwan Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 227. Taiwan Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 228. Australia Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 229. Australia Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 230. Rest of Asia-Pacific Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 231. Rest of Asia-Pacific Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 232. Europe Edible Vaccines Sales, by Country K Units (2025-2030)
  • Table 233. Europe Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 234. Europe Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 235. Germany Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 236. Germany Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 237. France Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 238. France Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 239. Italy Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 240. Italy Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 241. United Kingdom Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 242. United Kingdom Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 243. Netherlands Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 244. Netherlands Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 245. Rest of Europe Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 246. Rest of Europe Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 247. MEA Edible Vaccines Sales, by Country K Units (2025-2030)
  • Table 248. MEA Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 249. MEA Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 250. Middle East Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 251. Middle East Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 252. Africa Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 253. Africa Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 254. North America Edible Vaccines Sales, by Country K Units (2025-2030)
  • Table 255. North America Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 256. North America Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 257. United States Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 258. United States Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 259. Canada Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 260. Canada Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 261. Mexico Edible Vaccines Sales, by Type K Units (2025-2030)
  • Table 262. Mexico Edible Vaccines Sales, by Application K Units (2025-2030)
  • Table 263. Edible Vaccines: by Type(USD/Units)
  • Table 264. Research Programs/Design for This Report
  • Table 265. Key Data Information from Secondary Sources
  • Table 266. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Edible Vaccines: by Type USD Million (2018-2023)
  • Figure 5. Global Edible Vaccines: by Application USD Million (2018-2023)
  • Figure 6. South America Edible Vaccines Share (%), by Country
  • Figure 7. Asia Pacific Edible Vaccines Share (%), by Country
  • Figure 8. Europe Edible Vaccines Share (%), by Country
  • Figure 9. MEA Edible Vaccines Share (%), by Country
  • Figure 10. North America Edible Vaccines Share (%), by Country
  • Figure 11. Global Edible Vaccines: by Type K Units (2018-2023)
  • Figure 12. Global Edible Vaccines: by Application K Units (2018-2023)
  • Figure 13. South America Edible Vaccines Share (%), by Country
  • Figure 14. Asia Pacific Edible Vaccines Share (%), by Country
  • Figure 15. Europe Edible Vaccines Share (%), by Country
  • Figure 16. MEA Edible Vaccines Share (%), by Country
  • Figure 17. North America Edible Vaccines Share (%), by Country
  • Figure 18. Global Edible Vaccines: by Type USD/Units (2018-2023)
  • Figure 19. Global Edible Vaccines share by Players 2023 (%)
  • Figure 20. BCG Matrix for key Companies
  • Figure 21. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2023
  • Figure 23. Merck & Co. Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Merck & Co. Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Sanofi-Pasteur (France) Revenue, Net Income and Gross profit
  • Figure 26. Sanofi-Pasteur (France) Revenue: by Geography 2023
  • Figure 27. Merial (France) Revenue, Net Income and Gross profit
  • Figure 28. Merial (France) Revenue: by Geography 2023
  • Figure 29. Santa Cruz Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 30. Santa Cruz Animal Health (United States) Revenue: by Geography 2023
  • Figure 31. Global Edible Vaccines: by Type USD Million (2025-2030)
  • Figure 32. Global Edible Vaccines: by Application USD Million (2025-2030)
  • Figure 33. South America Edible Vaccines Share (%), by Country
  • Figure 34. Asia Pacific Edible Vaccines Share (%), by Country
  • Figure 35. Europe Edible Vaccines Share (%), by Country
  • Figure 36. MEA Edible Vaccines Share (%), by Country
  • Figure 37. North America Edible Vaccines Share (%), by Country
  • Figure 38. Global Edible Vaccines: by Type K Units (2025-2030)
  • Figure 39. Global Edible Vaccines: by Application K Units (2025-2030)
  • Figure 40. South America Edible Vaccines Share (%), by Country
  • Figure 41. Asia Pacific Edible Vaccines Share (%), by Country
  • Figure 42. Europe Edible Vaccines Share (%), by Country
  • Figure 43. MEA Edible Vaccines Share (%), by Country
  • Figure 44. North America Edible Vaccines Share (%), by Country
  • Figure 45. Global Edible Vaccines: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • GlaxoSmithKline Plc. (United Kingdom)
  • Merck & Co. Inc. (United States)
  • Sanofi-Pasteur (France)
  • Merial (France)
  • Santa Cruz Animal Health (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 143 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Edible Vaccines Market Quantitative research analysis
Global Edible Vaccines Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as GlaxoSmithKline Plc. (United Kingdom), Merck & Co. Inc. (United States), Sanofi-Pasteur (France), Merial (France) and Santa Cruz Animal Health (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Rapid Advancement In Technologies Particularly in the Healthcare Sector" is seen as one of major influencing trends for Edible Vaccines Market during projected period 2023-2030.
The Edible Vaccines market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Edible Vaccines Market Report?

Have a Query? Click Here

Other Related Reports

Valley Fever Treatment Comprehensive Study by Application (People, Cattle, Sheep and Goats, Camel, Others), Treatment for Pets (Fluconazole (Diflucan), Itraconazole (Sporanox), Ketoconazole (Nizoral)...
$ 3450
Primary Immunodeficiency Diseases Treatment Comprehensive Study by Type (Immunoglobulin Replacement Therapy, Stem Cell/Bone Marrow Transplantation, Antibiotic Therapy, Gene Therapy, Others), Applicat...
$ 3800
Craniomaxillofacial Implants Comprehensive Study by Type (Titanium and Alloys, Polymers/Biomaterials, Calcium Phosphate Ceramics), Application (External Fixators, Internal Fixators), Material (Metal...
$ 3800
Constipation Treatment Drug Comprehensive Study by Type (Laxatives, Chloride Channel Activators, 5-HT4 Receptor Agonists, GC-C Agonists, Peripherally Acting Mu-Opioid Receptor Antagonists), Applicati...
$ 3750
Hepatic Encephalopathy Comprehensive Study by Application (Acute Liver Failure, Portal Systemic Bypass Without Liver Disease, Liver Cirrhosis), End users (Hospitals, Research Institutes, Clinics & Su...
$ 3750
Short Bowel Syndrome Comprehensive Study by Type (GLP-2, Growth Hormone, Glutamine, Others), Application (Hospitals, Clinics), Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Others)...
$ 3350